SUMMARY
The objective of this study was to assess whether eosinopenia was a reliable diagnostic marker of bloodstream infection in hospitalised adult and paediatric patients. The design was a case-control study, set in a tertiary adult and paediatric hospital.
A total of 157 adult and 85 paediatric patients with bloodstream infection ('cases') were compared to 195 and 94 randomly selected adult and paediatric patients who had clinical suspicion of bloodstream infection but with a negative blood culture ('controls') respectively. Patients with haematological or immunosuppressive disease and control patients who were treated with antibiotics within one week prior to the blood culture were excluded.
Eosinopenia, or undetectable eosinophil count (<0.01×10 9 or <10/mm 3 ) , was more common among the cases than the controls (46.5% vs 21.5%, respectively). The specificity of eosinopenia to predict bloodstream infection in adult patients was reasonable (79%, 95% confidence interval [CI] 74 to 82), but its sensitivity was low (47%, 95% CI 41 to 52). The absolute eosinophil count only had a modest ability to discriminate bloodstream infections from controls in adult patients (area under receiver operating characteristic curve 0.349, 95% CI 0.288 to 0.411). Eosinophil counts had very little overall predictive ability (area under receiver operating characteristic curve 0.448, 95% CI 0.363 to 0.533, P=0.237), and the sensitivity (54%, 95% CI 47 to 61) and specificity (56%, 95% CI 49 to 63) of eosinopenia to predict bloodstream infection in paediatric patients were both low. In the multivariate analyses, only C-reactive protein concentrations and neutrophil counts, but not eosinopenia, were significantly associated with the presence of bloodstream infection in both adult and paediatric patients.
The presence of eosinopenia can be considered as an inexpensive warning test for bloodstream infection in hospitalised adult patients so that further investigations can be initiated. An absence of eosinopenia is, however, not sensitive enough to exclude bloodstream infection. C-reactive protein concentrations and neutrophil counts were both better markers of bloodstream infection than eosinopenia in hospitalised paediatric and adult patients.
Recently, there has been a resurgence of interest in using eosinopenia as a biomarker of infection. Eosinopenia has a strong correlation with leukocytosis in bacterial infection 9 and, using a clinical definition of infection, eosinopenia appears to be superior to a commonly used inflammatory marker -serum C-reactive protein (CRP) concentrationsin distinguishing infection causing systemic inflammatory response from a non-infective cause 10 . Because bloodstream infection is a more objective and clearly delineated form of infection, it is the preferred endpoint for assessing the diagnostic utility of eosinopenia. Our recent study has indeed shown that eosinopenia is very common (86%) in critically ill patients with bloodstream infection confirmed by positive blood cultures 11 . This study was, however, limited by its small sample size and a lack of a paediatric cohort.
We hypothesised that eosinopenia is a reliable marker of bloodstream infection in both hospitalised paediatric and adult patients, and conducted a casecontrol study to assess its diagnostic accuracy as a marker of bloodstream infection, and whether eosinopenia could give additional diagnostic information when combined with the usual conventional markers of infection such as serum CRP concentrations and neutrophil counts.
METHODS

Patient population and measurements
This case-control study was assessed by the Hospital Ethics Committee at Royal Perth Hospital (RPH) and Princess Margaret Children's Hospital (PMH) in Western Australia, and was deemed a 'clinical audit'. Western Australia has a population of 2.2 million and Perth, the capital city, has a population of 1.65 million. All tertiary medical services for Western Australia are situated in Perth. RPH is a 580-bed tertiary university teaching hospital with all medical and surgical specialties represented, including heart and lung transplantation. PMH is the only children's hospital in Western Australia.
Consecutive patients with a positive blood culture ('cases') and concurrent randomly selected 'controls' (negative blood culture) between 1 October 2008 and 19 October 2009 at PMH, and between 1 November 2008 and 30 November 2009 at RPH were identified from the Microbiology Laboratory Management Systems Database of both hospitals. The data custodians of the microbiology departments of the two study hospitals independently selected the control patients from the bloodstream infection databases in a random fashion. These two data custodians were not involved in the subsequent data extraction and analysis process in this study. A matched case-control method was not used in this study, because once covariates were matched the significance of the matched covariates could not be analysed in the multivariate analyses.
The medical records of patients with a positive blood culture were reviewed to ensure that the clinical microbiologist and attending clinician both considered the micro-organism in the blood culture as pathological and not a contaminant. All cases and controls had clinical features of systemic infection and suspicion of bloodstream infection. Blood cultures growing coagulase-negative Staphylococcus species were excluded prior to review of medical notes, because this organism frequently represents contamination. The medical records of all controls were also reviewed and patients were excluded if they were treated with antibiotics within one week prior to obtaining the blood culture. Patients who had primary haemotological disorders, immunodeficiency syndromes (e.g. Human Immunodeficiency Virus), as well as those who were treated with chemotherapy or immunosuppressive medications (e.g. corticosteroids, methotrexate, cyclosporin) were also excluded in this study.
All results analysed in this study were performed as part of their clinical management by the treating clinicians. The clinical data analysed included age, gender and mortality data of the patients. The potential markers of bloodstream infection assessed in this study included serum CRP concentrations, total white cell, neutrophil and eosinophil count, all measured within 24 hours of obtaining the blood cultures. Serum CRP concentrations were measured by an immunoenzyme analyser (Hitachi 917, Tokyo, Japan) at RPH and PMH. Eosinophil counts were determined by an automated method with minimal measurable eosinophil counts of 0.01×10 9 .l -1 (10 /mm 3 ). Eosinophil counts of less than 0.01×10 9 .l -1 (10 /mm 3 ) were not measurable and defined as eosinopenia in this study.
Statistical analyses
Categorical and continuous variables with skewed distributions were analysed by chi-square and Mann-Whitney U tests respectively. Area under the receiver operating characteristic curve (AUROC) was used to assess the predictive value of different inflammatory markers. Because the normal ranges of the total white cell, neutrophil and eosinophil count in the paediatric patients vary significantly between different age cohorts before 18 years of age, the percentage of the upper limit of normal for patients younger than 18 years old was used instead of absolute count in assessing their predictive effect by AUROC. Sensitivity and specificity of eosinopenia and an arbitrarily chosen CRP concentration of >100 mg.l -1 as a marker of bloodstream infection were also calculated.
All inflammatory markers were entered into multivariate logistic regression analysis to assess the independent predictive effect of each marker and no variables were removed in the multivariate analyses. A P value of <0.05 was regarded as statistically significant, 95% confidence interval (CI) was used to quantify uncertainty, and all statistical tests in this study were performed with SPSS for Windows (version 13.0 SPSS Inc. IL, USA, 2005).
RESULTS
Among a total of 502 adult patients with a positive blood culture and 551 adult patients with infection but without a positive blood culture, 157 and 195 patients were selected as 'cases' and 'controls', respectively. Among a total of 463 paediatric patients with a positive blood culture and 403 paediatric patients with infection but without a positive blood culture, 85 and 94 paediatric patients were considered as 'cases' and 'controls' respectively ( Figure 1) .
A total of 165 and 92 episodes of bloodstream infections among the 157 adult and 85 paediatric 'cases' were identified during the study period, respectively. Eight adult and seven paediatric patients had more than one organism in the same blood culture specimen when the diagnosis of bloodstream infection was made. Seventy of the 165 bloodstream infections in the adult patients (42.4%) were due to Gram-positive organisms, 91 (55.2%) were due to Gram-negative organisms and four (2.4%) were due to fungal organisms. Among the 92 bloodstream infections in the paediatric patients, 60 (65.2%) were due to Gram-positive organisms, 29 (31.5%) were due to Gram-negative organisms and three (3.3%) were due to fungal organisms. The median eosinophil count in the adult patients with bloodstream infection was significantly lower than those of the controls (0.07 vs 0.18×10 9 .l -1 [70 vs 180 /mm 3 ], respectively, P=0.001). Eosinopenia, unmeasurable eosinophil count, was significantly more common among the cases than the controls (46.5% vs 21.5%, respectively, P=0.001). The CRP concentrations, total white cell and neutrophil count were also significantly higher among the cases than the controls (Table 1 ).
In the univariable analyses, the total white cell count (AUROC 0.569, 95% CI 0.506 to 0.632), neutrophil count (AUROC 0.615, 95% CI 0.554 to 0.677), eosinophil count (AUROC 0.349, 95% CI 0.288 to 0.411), and the CRP concentrations (AUROC 0.680, 95% CI 0.621 to 0.739) all had some degree of predictive ability as a marker of bloodstream infection in adult patients ( Table 2 and Figure 2 ). The specificity of eosinopenia to predict bloodstream infection in adult patients was reasonable (79%, 95% CI 74 to 82), but its sensitivity was low (47%, 95% CI 41 to 52). CRP >100 mg.l -1 was more sensitive but less specific than eosinopenia as a marker of bloodstream infection in adult patients (sensitivity: 62%, 95% CI 57 to 67 vs 47%, 95% 41 to 52 and specificity: 66%, 95% CI 61 to 71 vs 79%, 95% 74 to 82).
In contrast to the adult patients, eosinophil count and eosinopenia were not significantly different between paediatric cases and controls ( Table 3) . CRP concentrations and neutrophil counts were however, significantly different between the cases and controls. In fact, CRP concentrations (AUROC 0.748, 95% CI 0.675 to 0.820, P=0.001) had the best predictive ability when used alone in paediatric patients ( Table 3 and Figure 2 ). Using CRP concentration >100 mg.l -1 as a predictor, the specificity of CRP to predict bloodstream infection in paediatric patients was very high (93%, 95% CI 89 to 96), but its sensitivity was very low (31%, 95% CI 24 to 38). Eosinophil count has very little overall predictive ability (AUROC 0.448, 95% CI 0.363 to 0.533, P=0.237) and the sensitivity (54%, 95% CI 47 to 61) and specificity (56%, 95% CI 49 to 63) of eosinopenia to predict bloodstream infection in paediatric patients were both low. Multivariate analyses confirmed that the CRP concentrations, total white cell and neutrophil counts were independent predictors of bloodstream infection in both paediatric and adult patients ( Table 4 ), but not eosinophil count.
DISCUSSION
Our results showed that eosinopenia was common (46.5%) and had a reasonable specificity (79%) as a marker of bloodstream infections in adult patients. Eosinopenia was, however, not sensitive and its overall predictive ability was not high as a marker of bloodstream infection in adult patients. The use of eosinopenia as a marker of bloodstream infection was very limited in paediatric patients. Neutrophil counts and CRP concentrations both appeared to be better markers of bloodstream infection than eosinopenia in paediatric patients. Although eosinophils only account for a very small proportion of the peripheral white blood cells, their production is tightly regulated by interleukin-3, interleukin-5 and granulocyte-macrophage colonystimulating factor 3,10,12 . Without these three cytokines, eosinophils survive for less than 48 hours 12 . These three cytokines are however, not significantly activated in patients with sepsis 13 and as such, it is believed to be the main mechanism resulting in eosinopenia in patients with severe sepsis and bloodstream infections 3, 14, 15 . Our results confirmed that eosinopenia is common in adult patients with bloodstream infections 14, 15 . Although eosinopenia has a reasonable specificity (79%) as a marker of bloodstream infection in adult patients, its sensitivity is low. Furthermore, eosinopenia does not appear to be useful when combined with CRP concentrations, total white cell and neutrophil counts ( Table 4 ). These results suggest that the presence of eosinopenia can be considered as an inexpensive warning test for bloodstream infections in adult patients so that further investigations can be initiated to exclude bloodstream infection. An absence of eosinopenia is, however, not sensitive enough to exclude bloodstream infection in hospitalised adult patients.
Although earlier studies suggested that eosinopenia could also be useful as a marker of infection in paediatric patients 16, 17 , we could not confirm the findings of these studies. Furthermore, we found that CRP concentration and neutrophil count were better markers of bloodstream infection than eosinopenia. There are a few possible explanations for these results. First, we have included very young paediatric patients with bloodstream infection (median age two years old). Very young patients, especially neonates, may have an immature immune response and subtle differences in the activation of cytokines in response to bloodstream infection 18 . Second, the sample size of our study was bigger than the previous studies and we have also excluded the confounding effect of antibiotic therapy in the control group. Third, our patients were sicker than the patients reported in the previous reports 16, 17 . Bloodstream infection is a more objective and clearly delineated endpoint of sepsis than clinical infection. It is possible that bloodstream infection induces a more significant generalised systemic inflammation than localised infection 13 . Fourth, children generally have a shorter prodrome than adults and thus, the expected drop in eosinophil count may not have yet occurred. As such, it is possible that the relative ability of CRP, neutrophil counts and eosinopenia in differentiating infections is different, depending on the severity of systemic inflammation and amount of chemotactic factors released into the systemic circulation.
This study has limitations. First, although the sample size of this observational study was reasonably large, it may still be underpowered to demonstrate the potential predictive ability of eosinopenia as a marker of bloodstream infection, especially in paediatric patients. Second, we only had a small number of patients with fungaemia (n=7). The ability of eosinopenia to serve as a better marker of fungaemia remains uncertain, but this merits further investigation by a large study. Third, we have not included other biomarkers. We are not aware of any studies that have compared eosinopenia with procalcitonin, which may be a better marker of sepsis than CRP 19, 20 . Fourth, we did not collect clinical data other than age, gender and mortality of the study patients. Clinical data such as symptoms of rigor, body temperature, chest X-ray changes and comorbidities may provide additional information on the characteristics of the cases and controls, but including a substantial number of covariates in the analyses would have exceeded the power of the study. Finally, we have excluded patients who have haematological diseases and immunosuppressive therapy, and tropical infectious diseases occur rarely in our study centres. As such, our findings are not generalisable to these patients or to centres with a high prevalence of tropical infectious diseases.
Our study used a cut-off of less than 0.01×10 9 /l or 10 cells/mm 3 to determine eosinopenia. A more sensitive measurement may improve the diagnostic utility. However, our results suggest that when eosinopenia was modelled as a continuous variable, its diagnostic utility as a marker of bloodstream infection was limited as evidenced by its area under the receiver operating characteristic curve.
In summary, the presence of eosinopenia can be considered as an inexpensive warning test for bloodstream infection in hospitalised adult patients so that further blood tests and investigations can be initiated to exclude bloodstream infection. However, an absence of eosinopenia does not exclude bloodstream infection in hospitalised adult patients. The use of eosinopenia, as a marker of bloodstream infection, is very limited in hospitalised paediatric patients. Neutrophil counts and CRP concentrations are better markers of bloodstream infection than eosinopenia in this group.
